Nocdurna contains Desmopressin as its active component. Desmorphin is a synthetic analogue of the natural hormone antidiuretic hormone (ADH). In Hong Kong, Nocdurna is available by prescription as a 0.2 mg tablet and is classified under urological health medicines. It is regulated by the Hong Kong Department of Health and requires a medical prescription.
Desmopressin mimics the action of ADH, binding to V2 receptors in the kidneys. This stimulates water reabsorption in the collecting ducts, reducing urine volume. By concentrating the urine, the drug helps manage conditions where excessive nighttime urination or dilute urine production occurs. Effects typically begin within 30 minutes after oral administration, peak around 1-2 hours, and may last up to 8 hours.
These uses are approved by the Hong Kong regulatory authorities for the listed indications. Treatment is individualized based on patient age, severity of symptoms, and renal function.
These reactions are usually mild and resolve without medical intervention.
If any signs of severe hyponatraemia (e.g., persistent vomiting, lethargy, sudden weight gain) appear, seek medical attention promptly.
Patients should inform their healthcare provider of all current medicines, including over-the-counter products and herbal supplements.
This article provides educational information about Nocdurna and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Nocdurna does not directly affect blood pressure, but uncontrolled fluid retention can raise blood pressure in susceptible individuals. Patients with hypertension should have their blood pressure monitored regularly while on therapy.
Yes, but keep the medication in its original packaging with the prescription label. Carry a copy of the prescription and be aware of any destination-specific import regulations for prescription drugs.
The tablet is typically white, round, and imprinted with the strength code “0.2 mg” or a specific alphanumeric identifier assigned by the manufacturer. Verify the imprint against the pharmacy label.
Desmopressin is not a prohibited substance under most sports anti-doping codes, but athletes should disclose its use to the relevant testing authority and retain a therapeutic use exemption if required.
All desmopressin products contain the same active ingredient and share similar mechanisms. Differences may lie in tablet formulation, packaging, and regional brand naming. Clinical efficacy is expected to be comparable when the dosage is equivalent.
Caffeine has a mild diuretic effect, which could modestly increase urine output. While it usually does not counteract desmopressin, limiting excessive caffeine in the evening may help achieve better nighttime control.
Moderate salt intake is acceptable and can help maintain normal serum sodium levels. drastic restriction is not required unless a healthcare provider advises otherwise based on individual lab results.
Switching formulations should be done only under medical supervision, as dosing equivalence differs between nasal and oral routes. Your physician can calculate an appropriate tablet dose.
Symptoms include sudden weight gain, swelling of the hands or feet, severe headache, nausea, and confusion. If these occur, seek medical attention promptly.
Many patients notice a reduction in nighttime urine volume within a few days, but full therapeutic benefit may require several weeks of consistent use and proper fluid-restriction habits.
